Knowing of the significant prevalence of depressive disorders in patients with cancer and of
the clinical relevance of depression to health outcomes, the Program in Evidencebased …

Depressive disorders such as MD, dysthymic disorder (DD), minor depression, and
adjustment disorder with depressed mood are associated with significant disability, impaired …

The diagnosis and treatment of depression in the cancer setting can improve patients'
quality of life, their adherence to therapy recommendations, and the illness experience, all of …

The continuum of severity in cancer-related depression is important to consider in
management approaches. Choice of treatment should be personalized to the patient and …

Depression is frequent in cancerology. Despite its clear impact on patients, it continues to be
under-diagnosed and inadequately treated. There are many reasons for this, ranging from …

Question: What is the efficacy of pharmacologic and non-pharmacologic treatments for major
depression and other depressive disorders in cancer populations? Perspectives …

Depression is common in people with cancer. Disabilities arising from it or depression itself
can be quite severe and its consequence includes poor quality of life, poor adherence to …

Purpose: This report updates the Cancer Care Ontario Program in Evidence-Based Care
guideline for the management of depression in adult patients with cancer. This guideline …

Major depressive disorder is a relapsing syndrome with grave morbidity and mortality. Much
like asthma, it has a genetic predisposition and environmental triggers. Specific …

Despite its high prevalence and clear impact on patients' quality of life as well as on survival
and inequalities to care and access to care, depression continues to be underdiagnosed …